References
- Clayton, A., Malone, W. J., Clarke, P., Mason, J., & D’Angelo, R. (2021, December 22). Commentary: The signal and the noise – questioning the benefits of puberty blockers for youth with gender dysphoria – a commentary on Rew et al. (2021). Child and Adolescent Mental Health, doi:10.1111/camh.12533
- Cohen-Kettenis, P. T., van Goozen, S. H. M. (1997). Sex reassignment of adolescent transsexuals: A follow-up study. Journal of the American Academy of Child & Adolescent Psychiatry, 36(2). 263–271. doi:10.1097/00004583-199702000-00017
- Katz, A. L., Macauley, R. C., Mercurio, M. R., Moon, M. R., Okun, A. L., Opel, D. J. & Statter, M. B. (2016). Informed consent in decision-making in pediatric practice. Pediatrics, 138(2), e20161484 doi:10.1542/peds.2016-1485
- Levine, S. B. (2022). Reconsidering informed consent for trans-identified children, adolescents, and young adults. Journal of Sex and Marital Therapy.
- National Institute for Health Care and Excellence. (2021a, March 11). Evidence review: Gonadotrophin releasing hormone analogues for children and adolescents with gender dysphoria. National Institute for Health Care and Excellence, NHS England.
- National Institute for Health Care and Excellence. (2021b, March 11). Evidence review: Gender affirming hormones for children and adolescents with gender dysphoria. National Institute for Health Care and Excellence, NHS England.
- Ostergaard, S. D. (2017). Taking Facebook at face value: why the use of social media may cause mental disorder. Acta Psychiatrica Scandinavica, 136: 439–440.
- Rew, L., Young, C. C., Monge, M., & Bogucka, R. (2021). Review: Puberty blockers for transgender and gender diverse youth-a critical review of the literature. Child and Adolescent Mental Health, 26(1): 3–14.
- Yarbrough, E. (2018) Transgender mental health. Washington, DC: American Psychiatric Association Publishing.